Suchergebnisse - "Beltrán, Belén"

PubPharm (45)

1

Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse

enthalten in: Digestive diseases and sciences | 2019

von Iborra, M. | Herreras, J. | Boscá-Watts, M. | +7

2

Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

enthalten in: Digestive diseases and sciences | 2018

von Chaparro, M. | Barreiro-de Acosta, M. | Echarri, A. | +21

3

Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease

enthalten in: Digestive diseases and sciences | 2017

von Sáez-González, E. | Moret, I. | Alvarez-Sotomayor, D. | +5

4

Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

enthalten in: Journal of gastroenterology | 2017

von Iborra, M. | Gisbert, J. | Bosca-Watts, M. | +24

5

Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

enthalten in: Journal of gastroenterology | 2016

von Iborra, M. | Gisbert, J. | Bosca-Watts, M. | +24

6

Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

enthalten in: Journal of gastroenterology | 2016

von Iborra, M. | Pérez-Gisbert, J. | Bosca-Watts, M. | +24

7

Tu1926 Evolution After Anti-TNF Drug Discontinuation in Patients With Inflammatory Bowel Disease (IBD): A Multicenter Long-Term Follow-Up Study

enthalten in: Gastroenterology | 2016

von Casanova, M. | Chaparro, M. | García-Sánchez, V. | +32

8

Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease

enthalten in: Gastrointestinal endoscopy clinics of North America | 2016

von Iborra, M. | Beltrán, B. | Nos, P.

9

Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

enthalten in: Journal of gastroenterology | 2016

von Iborra, M. | Gisbert, J. | Bosca-Watts, M. | +24

10

Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

enthalten in: Journal of gastroenterology | 2016

von Iborra, M. | Gisbert, J. | Bosca-Watts, M. | +24

1
2
3
4
5
Nächster »
[5]